CN Patent

CN101848698A — 含乙酸利卡西平的口服剂型

Assigned to Bial Portela and Cia SA · Expires 2010-09-29 · 16y expired

What this patent protects

本发明公开了一种药物组合物，所述药物组合物包含组合有适宜的赋形剂尤其是粘合剂和崩解剂的乙酸利卡西平，特别是乙酸艾司利卡西平。还公开了一种用于制备所述药物组合物的造粒法，尤其是湿式造粒法。

USPTO Abstract

本发明公开了一种药物组合物，所述药物组合物包含组合有适宜的赋形剂尤其是粘合剂和崩解剂的乙酸利卡西平，特别是乙酸艾司利卡西平。还公开了一种用于制备所述药物组合物的造粒法，尤其是湿式造粒法。

Drugs covered by this patent

Patent Metadata

Patent number
CN101848698A
Jurisdiction
CN
Classification
—
Expires
2010-09-29
Drug substance claim
No
Drug product claim
No
Assignee
Bial Portela and Cia SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.